David Anderson, PA
Physician Assistant · Salt Lake City, UTNPI 1356342539
Payments from drug & device makers
Across 199 payments — averaging $16.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$597
- Nestle Healthcare Nutrition Inc.$215
- Lilly USA, LLC$208
- AbbVie$203
- Merck$198
- Astellas Pharma US Inc$193
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,328100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 31 | $597 |
| Nestle Healthcare Nutrition Inc. | 10 | $215 |
| Lilly USA, LLC | 16 | $208 |
| AbbVie | 11 | $203 |
| Merck | 13 | $198 |
| Astellas Pharma US Inc | 12 | $193 |
| AstraZeneca | 14 | $192 |
| GSK | 13 | $191 |
| Novo Nordisk | 9 | $148 |
| Bayer | 6 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $110 |
| Pfizer | 6 | $96 |
| Novartis | 5 | $81 |
| Sunovion Pharmaceuticals Inc. | 5 | $80 |
| Amgen | 5 | $75 |
| Johnson & Johnson | 5 | $74 |
| Abbott | 4 | $72 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| Biohaven Pharmaceuticals, Inc. | 3 | $62 |
| Amarin Pharma, Inc. | 3 | $54 |
| Lucid Diagnostics Inc. | 3 | $45 |
| Upsher-smith Laboratories LLC | 2 | $37 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Indivior Inc. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 2 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Medicure Pharma Inc. | 1 | $21 |
| Exeltis, USA Inc. | 1 | $19 |
| Boston Scientific | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
How this compares
$3,328 in reported general payments places this provider in the 90th percentile of 1,543 physician assistant providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 76 | $66,252 |
| XareltoRivaroxaban | 35 | $45,882 |
| FarxigaDapagliflozin Propanediol | 42 | $35,986 |
| JardianceEmpagliflozin | 32 | $32,085 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $27,038 |
| TrulicityDulaglutide | 26 | $24,832 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $18,065 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 67 | $10,994 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 45 | $6,076 |
| MyrbetriqMirabegron | 12 | $6,055 |
| Levothyroxine Sodium | 316 | $4,281 |
| Omeprazole | 153 | $3,713 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $3,530 |
| Diclofenac Sodium | 139 | $3,117 |
| Atorvastatin Calcium | 233 | $2,947 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $96 | $66,25276 claims |
| Johnson & JohnsonXarelto | $74 | $45,88235 claims |
| AstraZenecaFarxiga | $192 | $35,98642 claims |
| Boehringer IngelheimJardiance | $597 | $32,08532 claims |
| Lilly USA, LLCTrulicity | $208 | $24,83226 claims |
| Astellas Pharma US IncMyrbetriq | $193 | $6,05512 claims |
| AbbVieSynthroid | $203 | $1,28025 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,543 physician assistant providers in Utah.
Other physician assistant in Salt Lake City
- Jill EricksonSalt Lake City$179K
- Natalie BeeSalt Lake City$63K
- Samuel ShewanSalt Lake City$22K
- Christy MaSalt Lake City$17K
- Shane FarrSalt Lake City$14K
- Gintare DaileySalt Lake City$13K
- Corey DahlSalt Lake City$13K
- David JonesSalt Lake City$12K
- Corbin WoodSalt Lake City$12K
- Amy HillierSalt Lake City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.